主催: The Japanese Pharmacological Society, The Japanese Society of Clinical Pharmacology
会議名: WCP2018 (18th World Congress of Basic and Clinical Pharmacology)
開催地: Kyoto
開催日: 2018/07/01 - 2018/07/06
TRPC6 channel activity is suppressed by the intracellular Ca2+ through a negative feedback regulation known as Ca2+-dependent inactivation (CDI), in which calmodulin (CaM) has been proposed to play a critical role. Here, our molecular mutations and dissections with functional and biophysical analysis have revealed new detail that equal contribution of N- and C-lobes of CaM to CDI and which could be accomplished by Ca2+-dependent CaM binding to the TRPC6 CaM-binding domain (CBD) in a 1:2 stoichiometry. This ensemble prerequisite was arranged via assembly of the coiled-coil segment adjacent to the CBD. The deletion of this segment markedly decelerated CDI of TRPC6 currents, suggesting that CDI is induced by bridging of two CBDs by a single CaM molecule. Naturally occurring gain-of-function TRPC6 mutations are involved in autosomal dominant focal segmental glomerulosclerosis (FSGS). Surprisingly, the FSGS-TRPC6 mutations in the coiled-coil severely hamper CDI and induce "rim-like" morphological changes in podocytes. Our study provides novel structural insights into the CDI of TRPC6 channel, and the disruption of CDI leads to the pathophysiological significance in kidney disease.